One quarter of the global population is estimated to have nonalcoholic fatty liver disease
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …

Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease worldwide and is associated with hepatocellular carcinoma (HCC), the most …

Non-alcoholic liver disease (NAFLD) defines liver abnormalities ranging from simple
steatosis to nonalcoholic steatohepatitis with or without cirrhosis development, occurring in …

The growing burden of non-alcoholic fatty liver disease (NAFLD) parallels the increasing
prevalence of obesity in Asia. The overall prevalence of NAFLD in Asia is now estimated to …

Non‐alcoholic fatty liver disease (NAFLD) is a major public health problem both in the
Western world and in the East. This is mainly due to the high prevalence of the disease and …

Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer‐related mortality worldwide. Non‐alcoholic fatty liver disease (NAFLD) …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health
problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is …

The increase in Non‐alcoholic Fatty Liver Disease (NAFLD) and the imminent
disappearance of chronic viral hepatitis thanks to new and effective therapies is motivating …

The global epidemiology of nonalcoholic fatty liver disease... : Hepatology The global
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …